Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

FSD Pharma Inc C.HUGE

Alternate Symbol(s):  HUGE

Healthcare Cannabis
FSD Pharma Inc. is a Canada-based biotechnology company. The Company operates through two segments: Biotechnology and Strategic Investments. Its Biotechnology segment is focused on furthering the research and development of the Company’s two primary drug candidates consisting of Lucid-MS and Lucid-PSYCH, as well as the development of UNBUZZD. The Company’s Strategic Investments segment is focused on generating returns and cashflow through the issuance of loans secured by residential or commercial real estate property. Lucid-PSYCH is a molecular compound identified for the potential treatment of mental health disorders. Lucid-MS is a molecular compound identified for the potential treatment of neurodegenerative disorders. UNBUZZD is a proprietary formulation of natural ingredients, vitamins, and minerals to help with liver and brain function for the purposes of potentially quickly relieving from the effects of alcohol consumption, such as inebriation, and restoring normal lifestyle.


CSE:HUGE - Post by User

FSD Pharma Inc
Bullboard Posts
User Avatar Image
(16)
•••
Post by MoneyTalks7on May 03, 2020 11:14pm
378 Views
Post# 30982162

Fibromyalgia Treatment Market

Fibromyalgia Treatment MarketIf anyone follows medical press releases, you always see Prismic Pharmaceuticals in the headlines. Companies like Pfizer, Novartis A6, Allergan, Aptinyx and Prismic always come out with their in-depth analysis on decent trends and growth opportunities for 2020-25.for fibromyalgia, and the future looks exciting.

What FSD currently has is Intellectual Property -----Prismic and their valuable patents

Top rated industry leaders with proven track records and extremely well respected amongst their peers.

Who would be their peers?? Big pharma of course, they are constantly looking on the sidelines for opportunities.

Stay safe everyone xoxo


Bullboard Posts
Dealroom for high-potential pre-IPO opportunities